| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |